HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Zomedica Pharmaceuticals Corp. (ZOM)
0.8874  -0.0161  (-1.78%) 06-21 03:45
Open: 0.9151 High: 0.92
Pre.close: 0.9035 Low: 0.8606
Volume: 38,188,764 Ave vol: 53,337,979
52w High: 2.91 52w Low: 0.063
MA(50): 0.858 MA(200): 1.143
EPS: -0.092 P/E Ratio: 0
Company profile
Exchange: AMEX
Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Website: http://zomedica.com
Market Cap (M): 865
Shares Out (M): 974
Zomedica Pharmaceuticals Corp. operates as a development stage veterinary diagnostic and pharmaceutical company. The company is headquartered in Ann Arbor, Michigan and currently employs 27 full-time employees. The firm is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. The company is focused on developing three diagnostic platforms, a Bulk Acoustic Wave sensor-based veterinary point-of-care diagnostic platform for performing immunodiagnostic testing, a Raman spectroscopy-based point-of-care diagnostic platform for the detection of pathogens, and liquid biopsy assays for the detection of cancer, along with related consumables. The Company’s TRUFORMA product candidate is an investigational device being developed as a point-of-care biosensor platform. ZM-020 is its diagnostic platform being developed to screen for a range of pathogens in companion animal feces, urine, respiratory, and dermatological samples. The company is developing ZM-017 as a canine cancer liquid biopsy platform.
Technical analysis
Overall: Underperform
MA: Bullish MACD: Bullish
KDJ: Bearish RSI: Bearish
Target 1: 1.09 Target 2: 1.24
Resist 1: 0.93 Resist 2: 1.06
Support 1: 0.73 Support 2: 0.61
Company key metrics
Revenue per Share: 0
Net Income per Share: 0.0464
Cash per Share: 0.0002
Book Value per Share: 0.1401
Price to Sales: 0
Price to Book Value: 6.5658
Earnings Yield: 0.0504
Dividend Yield: 0
Debt to Equity: 0
Debt to Assets: -0.0195
Financial analysis
Price to Book Value: Outperform
Return on Assets: Neutral
Return on Equity: Neutral
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.